Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| NanoSyrinx | 2024 | Series A | $13.1M | Coventry |
| Oxford Space Systems | 2024 | Venture - Series Unknown | $4.0M | Harwell |
| Baseimmune | 2024 | Series A | $11.4M | London |
| Trogenix | 2024 | Seed | $19.1M | Edinburgh |
| Mytos | 2023 | Series A | $19.0M | London |
| Bmll Technologies | 2023 | Seed | $10.5M | London |
| Mindgard Ltd | 2023 | Seed | $3.8M | London |
| Signaloid | 2023 | Seed | $3.7M | Cambridge |
| Funderbeam | 2023 | Venture - Series Unknown | $40.0M | London |
| CyberSmart | 2023 | Series B | $15.3M | London |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | NanoSyrinx | Series A | $13.1M | Coventry, United Kingdom |
| 27 | Oxford Space Systems | Venture - Series Unknown | $4.0M | Harwell, United Kingdom |
| 28 | Baseimmune | Series A | $11.4M | London, United Kingdom |
| 29 | Trogenix | Seed | $19.1M | Edinburgh, United Kingdom |
| 30 | Mytos | Series A | $19.0M | London, United Kingdom |
| 31 | Bmll Technologies | Seed | $10.5M | London, United Kingdom |
| 32 | Mindgard Ltd | Seed | $3.8M | London, United Kingdom |
| 33 | Signaloid | Seed | $3.7M | Cambridge, United Kingdom |
| 34 | Funderbeam | Venture - Series Unknown | $40.0M | London, United Kingdom |
| 35 | CyberSmart | Series B | $15.3M | London, United Kingdom |
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
OSS Is a space technology business that provides multi-award winning deployable antennas & structures made from proprietary materials.
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Trogenix operates as a therapeutics company.
Mytos is building a fully-automated cell manufacture platform for Pharma
BMLL Technologies is the top independent source for Level 3 Historical Data and Analytics catering to participants in the Capital Markets.
Mindgard Ltd provides AI security solutions, detecting and mitigating cyber threats for enterprise AI models.
Signaloid is a cloud-based computing platform.
Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes.
An all-in-one cybersecurity monitoring, optimisation, training and insurance platform proven to defend SMBs against the unexpected.
Swap Commerce provides an e-commerce operating system that helps online brands unify and manage their commerce operations.
Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.
Nevis is the world's first AI-powered platform designed specifically for wealth management.
Nu Quantum focuses on developing quantum networking hardware and software to scale quantum computers for practical use.
Mixx Technologies is a technology company.
Gravis Robotics specializes in turning existing earthmoving machinery into autonomous robots.
ST Labs is an AI service management platform handling requests and incidents to reduce manual coordination required to deliver IT services.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Isembard creates automated, software-powered factories for high-precision manufacturing in aerospace, defence, and energy.
Pronto is an on-demand home services platform that connects users with professionals for household tasks and other domestic help.
Grotto AI is an IT and Internet firm offering AI based tool for leasing and renewals.
Safe Online is a nonprofit organization
Aibuild offers the world’s most advanced Additive Manufacturing software.
Hometap is a fintech company allowing homeowners to tap their home equity without monthly payments.
Sierra provides a platform that builds and manages conversational AI agents for customer experiences.
IQ Capital has invested in 133 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IQ Capital's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Manufacturing, Information Technology. The firm invests across 51 different industry categories.
Among tracked funding rounds, Tropic Biosciences received $105.0M in a Series C round. IQ Capital's total known invested capital is $1.2B.
IQ Capital's average investment size is $20.6M across its portfolio of 133 companies.
Recent IQ Capital portfolio additions include NanoSyrinx, Oxford Space Systems, Baseimmune, Trogenix, Mytos. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors